Compounds > 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol
Page last updated: 2024-08-26

4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Carcinoma, Transitional Cell

4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol has been researched along with Carcinoma, Transitional Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chung, CJ; Hsueh, YM; Huang, CY; Lee, HL; Lin, P; Pu, YS; Su, CT; Wu, CC1

Other Studies

1 other study(ies) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Carcinoma, Transitional Cell

ArticleYear
Joint effect of arsenic methylation profile and NNK metabolites on urothelial carcinoma.
    The Journal of urology, 2012, Volume: 188, Issue:5

    Topics: Arsenic; Carcinoma, Transitional Cell; Case-Control Studies; Humans; Methylation; Nitrosamines; Pyridines; Risk; Smoking; Urologic Neoplasms

2012